Fundraising Fox

WHIN

Venture capitalActively deploying

New York

Fox Verdict
Sign up to see your fit

Fund manager profile

WHIN is a venture fund manager based in New York. SEC filings show 2 venture funds on record, most recently WHIN Opportunity Fund, LP filed September 2025.

Source: SEC EDGAR Form D filings. Firm website data not yet available.

HQ
New York, US
Founded
2021
Last 12 months
1 investment
Tracked investments
2

What they invest in

from 2 of 2 portfolio companies

Biotech ×2Digital Health ×1Healthtech ×1

HQs:United States×2

Investments · 2 tracked

founders shown can be your intro path

By year:2026 · 12025 · 12 dated

Allyx Therapeutics, Inc.allyxthera.comin𝕏May 2026SEC filingmedium confidence

Allyx Therapeutics is a clinical-stage biopharmaceutical company developing therapies to preserve and protect synapses in people with neurodegenerative diseases.

BiotechDigital HealthHealthtechNew Haven, US

Paul Fonteyne(Co-Founder)Stephen Strittmatter(Scientific Founder)Stephen Bloch(CEO, Co-Founder)Timothy Siegert(COO, Co-Founder)Jennifer Gabler(Executive Officer)

BoardRobert A. Bettigole(Director)in

Board seatGregory P HoGregory P. Ho· per SEC Form D · $30M raise · filed May 2026

Co-investorsElm Street VenturesSpring Mountain CapitalConnecticut Innovations

Episteme Prognostics, Inc.Mar 2025SEC filingmedium confidence

BiotechBrooklyn, US

Surajit Dhara(Executive Officer, Director)

BoardJason Rifkin(Director)Robert Warren(Director)

Board seatGregory P. Ho· per SEC Form D · $2.5M raise · filed Mar 2025

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Portfolio news

latest coverage across their companies

Frequently asked questions

Where is WHIN located?
WHIN is headquartered in New York, US.

Featured in lists